大华银行有限公司 | 受商业逆风影响

 
积极方面

+2020年二季度,已确认的9000万新元减值贷款津贴,仅占信贷成本的13个基点。
本季度确认的SP为13个基点,低于过去四个季度确认的20基点的季度平均水平。剩余3.78亿新元的GP,相当于占信贷成本的54个基点,均在20和21财年的之前信贷成本指引的50 – 60个基点范围内。

 
 
消极方面

– 2020年二季度,NII同比下降12%,这是因为NIM从一年前1.81% (-33个基点)收缩至1.48%的历史低点
除了整个季度处于低利率环境外,存款同比增长7%,超过了同期贷款3%的增速,加剧了NIM的大幅下降。2020上半年的NIM为1.60%,较去年同期的1.80%下降了20基点,而2020年一季度NIM获得较好的1.71%的表现,带来了一些缓冲。
存款重新定价和存款流入银行间资产的流动性循环的滞后效应,将在2020下半年缓解NIM的下行压力,因为我们预计NIM在整个2020财年,将从二季度的低点收复至1.58%。
– 观察到整个非利息收入普遍疲软。
2020年二季度,除了基金管理业务外,净费用和佣金收入均出现双位数下降(从5900万新元降至5700万新元,降幅达到3%)。信用卡费用和理财费用收入的疲软最为显著,分别从1.21亿新元和1.6亿新元下降至7600万新元和1.33亿新元,同比降幅分别为37%和17%,这是因为在2020年二季度期间实行熔断机制,致使商业活动受到严重的影响。
受净交易收入下降(从2.45亿新元降至2.32亿新元,同比下降5%)的影响,其他非利息收入在2020年二季度也下降了11%。

 
 
前景

MAS(新加坡金管局)宣布,按2019财年60%(1.30新元)的股息上限,每半年度股息为每股0.39新元。
修订后的股息金额,折合成2020财年的年化股息为0.78新元。这意味着股票红利也将不打折提供,因为银行认为,在观察到2020年一季度的CET-1为14.1%,保持在14.0%健康水平的同时,没有必要支撑额外的资本。
我们预计银行将在2021财年恢复50%的派息率,届时股息将至少恢复到每股1.10新元。
在未来两年内,对津贴的确认将维持在现行水平。
之前对信贷成本的指引,每年为50 – 60个基点(每年约为15亿新元),相当于未来两年内,每季度将获得3.5亿 – 4.2亿新元的津贴。加上3.79亿新元的RLAR,银行应能很好地对冲来自新冠疫情造成的资产质量恶化。

 
 
投资行动

我们维持增持建议,并下调目标价至20.40新元 (先前目标价为20.70新元)。
我们将2020财年末的收入预测下调5%,以反映受新冠疫情影响带来的业务复苏放缓。

 

如果有想了解更多全球股市资讯,请关注微信公众号 “辉立资本新加坡” (SGPSPL)。同时提供在线免费开设股票账户,一个账户轻松交易全球股票和ETF

美股,港股,新加坡股,中国A股,越南股票,韩国股票,德国股票,马来西亚股票,泰国股票,印尼股票,菲律宾股票,日本股票,澳大利亚股票,台湾股票,加拿大股票,英国股票,法国股票,荷兰股票,葡萄牙股票,比利时股票,土耳其股票

如果本文是英文翻译版本,一切请以英文为准

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com